|
 |
ZeaVision is pleased to announce the return of the 10mg zeaxanthin product
|
 |
| Boston, MA, June 28, 2007 6:00a.m. - 7:30a.m
:: ZeaVision sponsors an American Optometric Association Continuing Education Course: |
|
| St. Louis, MO, April, 2007
:: ZeaVision Adds Two More Prominent Doctors to its Advisory Board. |
|
| St. Louis, MO, August 28, 2006
:: ZeaVision Adds Three Leading Doctors to its Advisory Board. |
|
| St. Louis, MO August 11, 2006
:: Joseph M. Strout named new Chief Financial Officer and member of the Executive Committee for ZeaVision, LLC
|
|
| St. Louis, MO June 2, 2006
::Community Benefits from Eye Studies Conducted by the College of Optometry at the University of Missouri-St. Louis and ZeaVision
|
|
| ST. LOUIS, MO, May 24, 2006
::St. Louis Business Eyes Local Market As First In Country To Screen For AMD Risk
|
|
| May, 2006
::ZeaVision, LLC Announces Three New Business Developments
|
|
|
|
| ZeaVision’s QuantifEYE®
Program: First of its kind for assessing risk of developing Age-related Macular Degeneration
(AMD). ZeaVision has developed a 3-part AMD Risk Management program
consisting of an assessment of risk factors, a measurement of Macular Pigment Optical Density
(MPOD), and a retinal examination — all conducted by an eye care professional.
|
 |
For the eye care professional, QuantifEYE® is a unique program of AMD risk assessment
and intervention. AMD is reaching epidemic proportions and risk assessment for AMD has
always been a challenge... Until Now!
|
|
ZeaVision’s new program, QuantifEYE®, now gives eye care professionals the means to
determine potential risk for AMD. This program is affordable,
results are measurable, and testing is convenient.
|
 |
|
Baby Boomers are a generation now
facing the challenges of AMD. They are also more likely to be proactive in researching
their options for intervention. Early risk assessment and prevention needs to start with
patients in their 20’s. Eye care professionals now have the ability to assess risk for AMD,
take a proactive approach by providing a professionally formulated supplement to help reduce
the risk for developing this debilitating disease. This program allows for both the doctor
and the patient to see the positive benefits of supplementation on follow-up visits by
measuring the change in macular pigment ( a key risk factor.)
|
Eye Care Professionals
are at the forefront in prevention of eye disease.
Now patients can receive a comprehensive risk assessment that includes an evaluation of potential
health/history factors, measurement of their macular pigment levels, and a retinal exam.
This approach ensures everything possible is being done to aid in the prevention of this
devastating disease.
|
 |
|
click here to download information on measuring Macular Pigment
|
 |
|
When it comes to vision loss, don’t take a “wait and see” approach!
click here to learn more
|
|